Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Drug Pricing in South Korea
Hye Young Kwon
*
,
Brian Godman
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug Pricing in South Korea'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
New Medicines
100%
South Korea
100%
Drug Pricing
100%
Generic Drugs
50%
Reimbursement
50%
Curb
25%
Cost-effectiveness
25%
Pricing Policy
25%
Price Negotiation
25%
Payers
25%
New Standards
25%
Price Competition
25%
Study Review
25%
Pricing Measures
25%
National Health Insurance Service
25%
Repricing
25%
Efficient Measures
25%
Financial Efficiency
25%
Pricing Regulations
25%
Social Sciences
Drugs
100%
South Korea
100%
Pricing
100%
Literature Reviews
20%
Pricing Policy
20%
Korea
20%
National Health Insurance
20%
Legislation
20%
Cost-Effectiveness Analysis
20%
Insurance
20%
Economics, Econometrics and Finance
Pricing
100%
National Health Insurance
50%
Pricing Policy
50%
Insurance
50%
Pharmacology, Toxicology and Pharmaceutical Science
Generic Drug
100%